// App-Quantinova.ai

TCT-113 : Ten-Year Survival Benefit and Appropriateness of Surgical or Percutaneous Revascularization Based on Individual Predicted All-Cause Mortality in Patients With Complex Coronary Artery Disease

Researchers

Presenter

  • Patrick Serruys

Principal Investigators

  • Mohanad Hamandi

  • Chao Gao

  • Hironori Hara

  • Scot Garg

  • David van Klaveren

  • David Kent

  • Ewout W. Steyerberg

  • Yoshinobu Onuma

  • Daniel Thuijs

  • Piroze Davierwala

  • Arie Kappetein

  • David Holmes Jr.

  • Marie-Claude Morice

  • Bruce Lytle

  • Friedrich-Wilhelm Mohr

  • Michael Mack

Medical Centers

  • Heart Centre Leipzig, Leipzig, Germany

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • Tufts Medical Center, Boston, Massachusetts, USA

  • University of Toronto, TORONTO, Ontario, Canada.

  • Mayo Clinic, Rochester, Minnesota, USA

  • Department of Cardiology, Saolta Group, Galway University Hospital, Health Service Executive and National University of Ireland Galway (NUIG), Galway, Ireland

  • Baylor Cardiovascular Research Institute, Dallas, Texas

  • Baylor Scott & White-The Heart Hospital- Plano, Plano, Texas, USA

  • Royal Blackburn Hospital, Blackburn, United Kingdom

  • Xijing Hospital, Xi'an, Shaanxi, China

  • National University of Ireland Galway, Galway, Ireland

  • CERC, Massy, France

  • Cleveland Clinic Foundation, Cleveland, Ohio, USA

  • Erasmus Medical Center, Rotterdam, THE NETHERLANDS

  • Thoraxcenter Erasmus Medical Center, Rotterdam, the Netherlands

Locations

  • Germany

  • United Kingdom

  • Netherlands

  • China

  • United States

  • Ireland

  • Canada

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final